Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Azathioprine and Acenocoumarol Drug Interaction in Patients with Crohn’s Disease: A Case Report

Author(s): Syrine Ben-Hammamia*, Ons Charfi, Anis Belhadj, Amal Bouchrika, Faouzi Chebbi, Ghozlane Lakhoua and Sihem El Aidli

Volume 18, Issue 2, 2023

Published on: 28 June, 2022

Page: [267 - 269] Pages: 3

DOI: 10.2174/1574886317666220425113613

Price: $65

Abstract

Background: Acenocoumarol is an anticoagulant with numerous drug reactions. We report here, an unusual interaction between acenocoumarol and azathioprine.

Case Presentation: A 35-year-old woman, treated with acenocoumarol for thrombosis of the superior mesenteric vein, was prescribed azathioprine for Crohn’s disease. Three days later, INR values decreased from 2.36 to 1.48. The dose of acenocoumarol had to almost be doubled to reach an INR value of 2.56.

The interaction between azathioprine and acenocoumarol was then suspected. Few similar cases of interactions between azathioprine and another coumarin derivative, warfarin, have been reported. To our knowledge, this is the second case of such interaction reported with acenocoumarol in literature.

Conclusion: Thus, despite the rarity of this interaction reporting, we draw attention to the importance of close monitoring of INR values in patients treated with acenocoumarol associated with azathioprine.

Keywords: Azathioprine, acenocoumarol, drug interaction, drug monitoring, pharmacovigilance, side effects, case report.

« Previous Next »
[1]
Gschwind L, Rollason V, Lovis C, et al. Identification and weighting of the most critical “real-life” drug-drug interactions with acenocoumarol in a tertiary care hospital. Eur J Clin Pharmacol 2013; 69(3): 617-27.
[http://dx.doi.org/10.1007/s00228-012-1358-7] [PMID: 22903542]
[2]
Fernández MA, Regadera A, Aznar J. Acenocoumarol and 6-mercaptopurine: An important drug interaction. Haematologica 1999; 84(7): 664-5.
[PMID: 10406922]
[3]
Rekić D, Reynolds KS, Zhao P, et al. Clinical drug-drug interaction evaluations to inform drug use and enable drug access. J Pharm Sci 2017; 106(9): 2214-8.
[http://dx.doi.org/10.1016/j.xphs.2017.04.016] [PMID: 28435142]
[4]
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45.
[http://dx.doi.org/10.1038/clpt.1981.154] [PMID: 7249508]
[5]
Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007; 41(4): 674-80.
[http://dx.doi.org/10.1345/aph.1H423] [PMID: 17389673]
[6]
Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985; 40(2): 111-8.
[PMID: 4002188]
[7]
Singleton JD, Conyers L. Warfarin and azathioprine: An important drug interaction. Am J M 1992; 92(2): 217.
[http://dx.doi.org/10.1016/0002-9343(92)90116-S] [PMID: 1543209]
[8]
Rivier G, Khamashta M, Hughes G. Warfarin and azathioprine: A drug interaction does exist. Am J Med 1993; 95: 342.
[http://dx.doi.org/10.1016/0002-9343(93)90292-W]
[9]
Rotenberg M, Levy Y, Shoenfeld Y, Almog S, Ezra D. Effect of azathioprine on the anticoagulant activity of warfarin. Ann Pharmacother 2000; 34(1): 120-2.
[http://dx.doi.org/10.1345/aph.19148] [PMID: 10669196]
[10]
Havrda DE, Rathbun S, Scheid D. A case report of warfarin resistance due to azathioprine and review of the literature. Pharmacotherapy 2001; 21(3): 355-7.
[http://dx.doi.org/10.1592/phco.21.3.355.34208] [PMID: 11253860]
[11]
Walker J, Mendelson H, McClure A, Smith MD. Warfarin and azathioprine: Clinically significant drug interaction. J Rheumatol 2002; 29(2): 398-9.
[PMID: 11838865]
[12]
Ng HJ, Crowther MA. Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review. Am J Geriatr Pharmacother 2006; 4(1): 75-7.
[http://dx.doi.org/10.1016/j.amjopharm.2006.03.001] [PMID: 16730624]
[13]
Vazquez SR, Rondina MT, Pendleton RC. Azathioprine-induced warfarin resistance. Ann Pharmacother 2008; 42(7): 1118-23.
[http://dx.doi.org/10.1345/aph.1L077] [PMID: 18505911]
[14]
Castellino G, Cuadrado MJ, Godfrey T, Khamashta MA, Hughes GRV. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment. Ann Rheum Dis 2001; 60(5): 527-30.
[http://dx.doi.org/10.1136/ard.60.5.527] [PMID: 11302880]
[15]
Amato M, Mantha S, Corneau R, Sherry P, Tsapatsaris N. Azathioprine induced warfarin resistance: Case reports and potential interaction mechanism. J Thromb Thrombolysis 2008; 25(1): 111.
[http://dx.doi.org/10.1007/s11239-007-0119-4]
[16]
Kasperkiewicz K, Ponczek MB, Owczarek J, Guga P, Budzisz E. Antagonists of vitamin K-Popular coumarin drugs and new synthetic and natural coumarin derivatives. Molecules 2020; 25(6): 1-24.
[http://dx.doi.org/10.3390/molecules25061465] [PMID: 32213944]

Rights & Permissions Print Cite
Article Metrics
32
2
© 2024 Bentham Science Publishers | Privacy Policy